Associations of alveolar bone loss and interleukin-1 levels in one- and two-stage surgical procedures: a randomized prospective trial

dc.contributor.authorYildirim, Tuba Talo
dc.contributor.authorKaya, Filiz Acun
dc.contributor.authorYokus, Beran
dc.contributor.authorColak, Mehmet
dc.contributor.authorKaya, Eylem Ozdemir
dc.contributor.authorTekin, Giray
dc.contributor.authorSaribas, Ebru
dc.date.accessioned2024-04-24T16:24:16Z
dc.date.available2024-04-24T16:24:16Z
dc.date.issued2017
dc.departmentDicle Üniversitesien_US
dc.description.abstractObjective: Dental implants have been widely and successfully used in recent years as an alternative treatment for removable and fixed dental prostheses. The aim of this randomized prospective study was to determine the alveolar bone loss rate (ABLR) and IL-1 levels in one- and two-stage surgical procedures.Materials and methods: This study included 40 patients with a single missing tooth in the posterior mandible; dental implants were inserted using a one-stage surgical procedure (Group I) or a two-stage surgical procedure (Group II). All clinical periodontal parameters were recorded; peri-implant crevicular fluid (PICF) samples were collected before loading (T0) and during the third (T1) and sixth (T2) months after loading. ABLR values were evaluated at T0 and T2 by using dental tomography. PICF was analysed after T2 samples were collected. The study was registered through clinicaltrials.gov; identifier NCT03045458.Results: This study found that, the probing pocket depth was found to be significantly higher in Group I than Group II at both T1 and T2 (p<.05). There was no significant difference in other clinical parameters between the groups (p>.05). There was a significant difference between Group I ABLR values at T0 and T2 (p<.05). The PICF IL-1 levels were not significantly different between groups (p>.05).Conclusions: Within the limitations of the short observational period and small sample size of this study, two-stage implant placement shows comparable clinical outcomes to implants placed using a one-stage placement protocol.en_US
dc.description.sponsorshipScientific Research Project Coordinator of Dicle University, Diyarbakir, Turkey [10-DH-04]en_US
dc.description.sponsorshipThis study was supported by The Scientific Research Project Coordinator of Dicle University, Diyarbakir, Turkey [grant number: 10-DH-04].en_US
dc.identifier.doi10.1080/00016357.2017.1367959
dc.identifier.endpage615en_US
dc.identifier.issn0001-6357
dc.identifier.issn1502-3850
dc.identifier.issue8en_US
dc.identifier.scopus2-s2.0-85028576626
dc.identifier.scopusqualityQ2
dc.identifier.startpage608en_US
dc.identifier.urihttps://doi.org/10.1080/00016357.2017.1367959
dc.identifier.urihttps://hdl.handle.net/11468/16618
dc.identifier.volume75en_US
dc.identifier.wosWOS:000414914000010
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofActa Odontologica Scandinavica
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDental Tomographyen_US
dc.subjectInterleukin-1en_US
dc.subjectOne- And Two-Stage Dental Implantsen_US
dc.subjectPeri-Implant Crevicular Fluiden_US
dc.titleAssociations of alveolar bone loss and interleukin-1 levels in one- and two-stage surgical procedures: a randomized prospective trialen_US
dc.titleAssociations of alveolar bone loss and interleukin-1 levels in one- and two-stage surgical procedures: a randomized prospective trial
dc.typeArticleen_US

Dosyalar